For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
City Journal
Pointless Quarantine
New York’s restrictions on interstate travelers are overbroad and punish rather than protect New Yorkers. At the end of March, Rhode Island governor…
National Review
How Trump Can Help Reopen America’s Schools
It’s almost the middle of August, and many parents still have little idea if their kids will be able to go to school in a few…
The Wall Street Journal
The White House Prepared for a Pandemic
New York Gov. Andrew Cuomo launched the Democrats’ broadside against the Trump administration’s Covid-19 response. “Our current federal government is dysfunctional and incompetent,” he told…
Letters
CEI Joins Coalition Letter Opposing Most Favored Nation Drug Pricing Proposal
On behalf of the undersigned federal and state-based organizations, we write to express our grave concerns with the “most favored nation” (MFN) executive order to impose foreign…
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
Inside Sources
Government Contact Tracing Won’t Help Get Americans Back to Work, but Innovation Will
Contact tracing identifies people who have an infectious disease (cases) and people they came in contact with (contacts) who may have become infected.
